Evidence map›Paper›PMID 37509683›Full record

ArticleBiomedicines2023

Microphysiological Conditions Do Not Affect MDR1-Mediated Transport of Rhodamine 123 above an Artificial Proximal Tubule.

Negin Namazian Jam, Felix Gottlöber, Melanie Hempel, Yuliya Dzekhtsiarova, Stephan Behrens, Frank Sonntag, Jan Sradnick, Christian Hugo, Florian Schmieder

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Negin Namazian JamFraunhofer Institute for Material and Beam Technology IWS, 01277 Dresden, Germany.
Felix GottlöberFraunhofer Institute for Material and Beam Technology IWS, 01277 Dresden, Germany.
Melanie HempelFraunhofer Institute for Material and Beam Technology IWS, 01277 Dresden, Germany.
Yuliya DzekhtsiarovaFraunhofer Institute for Material and Beam Technology IWS, 01277 Dresden, Germany.
Stephan BehrensFraunhofer Institute for Material and Beam Technology IWS, 01277 Dresden, Germany.
Frank SonntagFraunhofer Institute for Material and Beam Technology IWS, 01277 Dresden, Germany.ORCID 0000-0002-5850-2199
Jan SradnickDepartment of Internal Medicine III, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Christian HugoDepartment of Internal Medicine III, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Florian SchmiederFraunhofer Institute for Material and Beam Technology IWS, 01277 Dresden, Germany.ORCID 0000-0003-3911-8965
Fraunhofer Institute for Material and Beam Technology · DEUniversity Hospital Carl Gustav Carus · DE

Funding

Federal Ministry of Education and Research 161 L0275B
6 · The paper itself

Abstract

Despite disadvantages, such as high cost and their poor predictive value, animal experiments are still the state of the art for pharmaceutical substance testing. One reason for this problem is the inability of standard cell culture methods to emulate the physiological environment necessary to recapitulate in vivo processes. Microphysiological systems offer the opportunity to close this gap. In this study, we utilize a previously employed microphysiological system to examine the impact of pressure and flow on the transportation of substances mediated by multidrug resistance protein 1 (MDR1) across an artificial cell-based tubular barrier. By using a miniaturized fluorescence measurement device, we could continuously track the MDR1-mediated transport of rhodamine 123 above the artificial barrier over 48 h. We proved that applying pressure and flow affects both active and passive transport of rhodamine 123. Using experimental results and curve fittings, the kinetics of MDR1-mediated transport as well as passive transport were investigated; thus, a kinetic model that explains this transport above an artificial tubular barrier was identified. This kinetic model demonstrates that the simple Michaelis-Menten model is not an appropriate model to explain the MDR1-mediated transport; instead, Hill kinetics, with Hill slope of

Indexed as

apparent permeabilitymicrophysiological systemsmultidrug resistance protein 1 (MDR1)proximal tubulerhodamine 123RPTEC/TERT1tariquidartransport kinetics

Identifiers

PMID37509683
PMCPMC10376999
OpenAlexW4385068115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.